N Engl J Med 2019;380: 347e57
And if you see an effect in areas of the brain, or you see the EEG, the bandwidth changing, you infer that youre getting blood-brain barrier penetration
In the STEP 1 trial published in the New England Journal of Medicine (2021), participants receiving semaglutide 2.4 mg weekly achieved an average weight loss of approximately 15% of body weight over 68 weeks, compared to 2.4% with placebo
Manufacturing improvements Peptide synthesis technology continues to advance
Genetic variants in the GIPR gene (such as rs1800437) may influence how effectively an individual responds to this dual-receptor mechanism
These medications also show cardiovascular and renal benefits, such as reducing blood pressure, improving endothelial function, and lowering the risk of cardiovascular events like myocardial infarction and stroke [6][16]